Radiopharmaceuticals and Lung Cancer
Podcast | English | 2024 | 54 Min
Image For Activity Cover
No Credit Offered

This episode of Lung Cancer Considered focuses on radiopharmaceuticals-- a unique class of drugs that may have the most immediate impact in neuroendocrine tumors. Host Dr. Stephen Liu leads a discussion with three respected international clinicians about how these therapies play a role in both diagnostics and therapeutics and how they may soon be expanding.

Podcast Hosts:
  • Stephen Liu, MD, Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics, Georgetown Lombardi Comprehensive Cancer Center, Washington, D.C., USA 

Podcast Guests: 

  • Aman Chauhan, MD, Assistant Professor of Medicine, Leader of the Neuroendrocrine Tumor Program and Co-Director of the Theranostic Program, University of Miami, Miami, FL, USA
  • Jaydira Del Rivero, MD, Associate Research Physician and Physician Scientist in the Developmental Therapeutics Branch, Director of the Neuroendocrine Tumor Program, National Cancer Institute, Bethesda, Maryland, USA
  • Ken Herrmann, MD, Chair of the Department of Nuclear Medicine, Universitatsmedizin Essen, Past Chair of the European Association of Nuclear Medicine Oncology & Theranostics Committee, Essen, Germany
Powered By